Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

European External Neurostimulation / Neuromodulation devices Market is Expected to Reach $279.01 million in 2018 - New Report by MicroMarket Monitor
  • USA - English


News provided by

MicroMarket Monitor

Sep 15, 2014, 10:30 ET

Share this article

Share toX

Share this article

Share toX

MicroMarket Monitor
MicroMarket Monitor

(PRWEB) September 15, 2014 -- The external Neurostimulation\Neuromodulation devices report defines and segments the concerned market in Europe with analysis and forecast of revenue. The market was valued $153.2 million in 2012 and is projected to grow at a developing CAGR of 10.5% from 2013 to 2018.

Key players in the European External Neurostimulation / Neuromodulation devices Market are Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.) & others.

Post this

Browse through the TOC of the external neurostimulation\neuromodulation devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of the market in the same region, and is supported by various tables and figures.
http://www.micromarketmonitor.com/market/europe-external-neurostimulation-9837556579.html

Europe accounts to be the second largest market for external neurostimulation/neuromodulation devices due to its rapidly aging population and higher incidence of chronic disorders, wide range of applications, and cost-effectiveness of the device. The European external neurostimulation/neuromodulation devices market is expected to grow at a CAGR of 10.5% in the next five years, primarily due to technical advances and patient-friendly techniques, such as minimally non-invasive procedures.

The procedure volume growth is significantly higher in Germany, France, and Italy as a result of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and the increasing awareness amongst people. On the basis of types, the external neurostimulation / neuromodulation devices segments itself into transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS) devices, these devices also experience a positive growth owing to an increased awareness for procedures and sophisticated diagnostic techniques. Amongst them, TENS devices have an accountable market size as they are inexpensive, easily available to the end-users, and are self-administered.

Speak to Analyst @
http://www.micromarketmonitor.com/contact/9837556579-speak_to_analyst.html

The lack of stringent regulations pertaining to these devices and wide usage by the end-users without medical prescription is also propelling their growth. Europe also turns out to be a preferred market for new product launches because of the ease in the process of gaining the CE mark approval process for medical devices, especially for neuromodulation, in comparison with the FDA process. However, the major restraints of this market are less-effective outcomes of the devices.

This market is segmented and forecast on the basis of types and the modalities of External neurostimulation\neuromodulation devices in the European region. The market divides itself into transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS) devices. On the basis of surgery procedures, the market is segmented into direct nerve repair, nerve grafting, and stem cell therapy. The market is further segmented and forecast on the basis of major countries, such as the Germany, France, the U.K., Italy, and Spain.

Early buyers will receive 10% customization on this report.
http://www.micromarketmonitor.com/contact/9837556579-request_for_customization.html

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market including the major companies which are into external neurostimulation\neuromodulation devices procedural products.

Related Reports:
North American External Neurostimulation / Neuromodulation devices Market
The report analyzes the external neurostimulation / neuromodulation devices market segmentation by 2 segments, namely, transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). All these segments experienced a positive growth till 2012, owing to an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $0.4 and $0.1 billion, the transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS) have been contributing around 80% and 21% towards the total external neuromodulation device market.
The procedure volume growth is significantly higher in this region as a result of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.
http://www.micromarketmonitor.com/market/north-america-external-neurostimulation-2396937734.html

Asian External Neurostimulation / Neuromodulation Market
TENS devices have an accountable market size as they are inexpensive, easily available to end-users, self-administered. The lack of tight regulations pertaining to these devices and wide usage by end-users without medical prescription is also propelling their growth. However, the treatment is found to be less effective in the long run, and this factor will restrain the growth of the external neurostimulation market.

The Asian external neurostimulation market is mainly driven by the aging population, higher incidence of chronic disorders, wide range of applications, cost-effectiveness of the device, and the rise in the demand of non–invasive therapy, among others. However, the major restraints of this market are less-effective outcomes of the device, less-advanced technology as compared to TMS, and evidence of the device providing better results when used with other non-invasive neuromodulation devices.
http://www.micromarketmonitor.com/market/asia-external-neurostimulation-1023656463.html

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Mr. Chandrasekhar K., MicroMarket Monitor, http://www.micromarketmonitor.com/, +91 9881155004, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.